Murray Score for Acute Lung Injury (ALI/ARDS)
Quantifies severity of acute lung injury / ARDS using 4 parameters. Also used to define criteria for ECMO referral (Murray score ≥ 3 despite optimal ventilation).
Score interpretation
Murray Score 0: No acute lung injury.
→ No specific intervention. Treat underlying cause. Lung-protective ventilation if intubated.
Murray Score 0.1–2.4: Mild to moderate ALI.
→ Lung-protective ventilation (TV 6 mL/kg IBW, PEEP titration). Treat underlying cause. Daily SOFA. Prone if P/F < 150 not improving.
Murray Score 2.5–3.0: Severe lung injury. ECMO may be indicated.
→ Refer to ECMO centre if Murray ≥ 3 despite optimal ventilation (6 mL/kg, FiO₂ > 0.9, PEEP ≥ 10, prone positioning). Neuromuscular blockade. Recruitment manoeuvres per local protocol.
Murray Score > 3: Severe ARDS. ECMO strongly indicated if no contraindications.
→ Urgent ECMO referral. Maintain 'ultra-lung-protective' ventilation (TV 4–6 mL/kg, low PEEP, low FiO₂) while awaiting ECMO. Involve senior intensivist.
Interpretation bands for the Murray Score. Apply clinical judgement and local guidance.
References
- Murray JF, et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720–723.
- Peek GJ, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–1363.
Related
Curated clinical cross-links plus same-class fallbacks.
- Dobutamine (Acute HF / Stress Echo) · Inotrope / Acute Heart Failure
- Milrinone · Inodilator / Acute Heart Failure
- Poractant Alfa (Porcine Surfactant) · Lung Surfactant (Respiratory Distress Syndrome — Neonatal)
- Mannitol (Osmotic Diuretic — Renal/Neurological) · Acute Oliguric Renal Failure / Raised ICP
- Dexamethasone (ICU / ARDS) · Systemic Corticosteroid
- Doxapram hydrochloride · Respiratory stimulant
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.